In this study we investigated the balance between activating and inhibitory
signals during T cell activation. We have used transgenic mice in which CD
8(+) T cells expressed an inhibitory receptor, Ly49A, and a specific activa
ting alpha beta TCR. This TCR recognizes an lymphocytic choriomeningitis vi
rus peptide in combination with H-2D(b). We observed a quantitative influen
ce on cellular responses that depended upon the activating signals received
through the TCR and the inhibitory signals received through Ly49A. By vary
ing the peptide concentration given to stimulating cells or target cells, w
e could adjust the amount of ligand available to trigger the TCR. At low do
ses of peptide, Ly49A-expressing T cells were unresponsive on target cells
that expressed H-2D(d), but responded against target cells without H-2Dd. H
owever, this inhibition could be overcome by increasing the peptide concent
ration or by addition of anti-Ly49A F(ab')(2) fragments. Thus, rather than
behaving as simple "off" switches, our data indicate that Ly49 receptors mo
dulate T cell signaling so that higher amounts of activating signals are re
quired for effector-cell responses.